Request Deal Involvement

RA Capital Management and Sectoral Asset Management led a $115m Series C round in Evommune.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

or

Principals

SYMBIOSIS

bidder

SYMBIOSIS

LONGWOOD FUND

bidder

LONGWOOD FUND

BEIERSDORF VENTURE CAPITAL

bidder

BEIERSDORF VENTURE CAPITAL

ALLOSTERY INVESTMENTS LP

bidder

ALLOSTERY INVESTMENTS LP

AVEGO BIOSCIENCE CAPITAL

bidder

AVEGO BIOSCIENCE CAPITAL

RTW INVESTMENTS

bidder

RTW INVESTMENTS

EVOMMUNE INC

target

EVOMMUNE INC

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

SECTORAL ASSET MANAGEMENT

bidder

SECTORAL ASSET MANAGEMENT

MARSHALL WACE

bidder

MARSHALL WACE

ADAR1 CAPITAL MANAGEMENT

bidder

ADAR1 CAPITAL MANAGEMENT

NEXTBIO CAPITAL

bidder

NEXTBIO CAPITAL

FEMHEALTH VENTURES

bidder

FEMHEALTH VENTURES

PIVOTAL BIOVENTURE PARTNERS LLC

bidder

PIVOTAL BIOVENTURE PARTNERS LLC

EQT LIFE SCIENCES

bidder

EQT LIFE SCIENCES

ANDERA PARTNERS

bidder

ANDERA PARTNERS

AMPLITUDE VENTURES

bidder

AMPLITUDE VENTURES

VERITION FUND MANAGEMENT

bidder

VERITION FUND MANAGEMENT

B CAPITAL GROUP

bidder

B CAPITAL GROUP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - RA Capital Management and Sectoral Asset Management led a $115m Series C round in Evommune.